from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2929/-

LFCtreatmentdescriptionclass of inhibitor

-0.571

Amikacinug/mL Amikacintranslation

0.438

Cap5-10ug/mL Capreomycintranslation

-0.232

Rox10-50 ug/mL Roxithromycintranslation

0.371

SM2-5 ug/mL Streptomycintranslation

-2.208

Tet5-10 ug/mL Tetracyclinetranslation

-0.404

Rif0.2-5ug/mL Rifampicintranscription

-0.113

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.011

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.474

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.047

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.115

Clofazimine10-13 ug/mL Clofaziminerespiration

0.479

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.589

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.369

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.475

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.544

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.404

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.905

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.038

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.754

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.708

KCN5-20 ug/mL Potassium cyaniderespiration

-0.316

NaN30.2-2 mM Sodium aziderespiration

1.169

Nigericin50 uM Nigericinrespiration

-0.911

TRC10-150 ug/mL Triclosanrespiration

-1.687

TRZ10-25 ug/mL Thioridazinerespiration

-1.600

Valinomycin0.5-10 uM Valinomycinrespiration

1.891

ZnSO42 mM ZnSO4respiration

-0.125

menadione6-10 ug/mL Menadionerespiration

-0.279

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.825

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.301

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.746

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.845

NRP_1Non-replicating persistence stage 1dosRassociated

0.850

Amp0.2mg/mL AmpicillincellWall

0.325

Cephalexin20-100 ug/mL CephalexincellWall

1.346

Cerulenin0.32-5 ug/mL CerulenincellWall

0.301

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.770

EMB10-20 ug/mL EthambutolcellWall

1.161

Eta12-40 ug/mL EthionamidecellWall

1.718

INH0.2-0.4 ug/mL IsoniazidcellWall

0.684

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.412

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.774

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.374

BZA0.12 mg/mL BenzamidearomaticAmides

-0.298

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.438

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.228

H2O24 mM hydrogen peroxideDNAdamaging

0.839

Levo10 ug/mL LevofloxacinDNAdamaging

0.873

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.687

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.746

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.093

UVUV-irradiationDNAdamaging

0.105

ARP41-4 ug/mL Antitubercular compound ARP4?

0.529

Antimycin12.5-50 ug/mL Antimycin A?

0.472

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.175

PA_110-50 ug/mL Antitubercular compound PA-1?

0.390

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.531

PA8240.2-2 ug/mL PA-824?

-1.091

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.229

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.152

Verapamil50 uM Verapamil?

0.097

mercaptoethanol2 mM 2-Mercaptoethanol?

0.683

methoxatin10-20 ug/mL Methoxatin?